Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.93
-0.09 (-1.25%)
At close: May 29, 2026, 4:00 PM EDT
6.90
-0.03 (-0.46%)
After-hours: May 29, 2026, 4:10 PM EDT
Kyntra Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7.44 | 6.44 | 29.62 | 46.8 | 140.73 | 235.31 | |
Revenue Growth (YoY) | - | -78.26% | -36.71% | -66.74% | -40.19% | 33.46% |
Cost of Revenue | 4.41 | 0.56 | 15.56 | 3.96 | 20.28 | 12.87 |
Gross Profit | 3.03 | 5.88 | 14.06 | 42.84 | 120.45 | 222.44 |
Selling, General & Admin | 25.46 | 27.71 | 49.33 | 86.48 | 124.69 | 123.93 |
Research & Development | 21.91 | 23.52 | 95.69 | 266.47 | 296.79 | 387.04 |
Other Operating Expenses | 0.45 | 0.55 | 19.45 | 12.61 | - | - |
Total Operating Expenses | 47.82 | 51.78 | 164.48 | 365.56 | 421.48 | 510.97 |
Operating Income | -44.79 | -45.9 | -150.42 | -322.72 | -301.03 | -288.53 |
Interest Income | 3.65 | 2.94 | 5.3 | 7.59 | 9.17 | -0.07 |
Interest Expense | -8.93 | -8.76 | -8.25 | -8.1 | -1.44 | -1.08 |
Other Non-Operating Income (Expense) | -6.58 | -6.58 | - | - | - | - |
Total Non-Operating Income (Expense) | -11.87 | -12.4 | -2.95 | -0.5 | 7.73 | -1.15 |
Pretax Income | -56.66 | -58.29 | -153.37 | -323.22 | -294.87 | -290.68 |
Provision for Income Taxes | 0.09 | 0.09 | 0.27 | 0.25 | -0.36 | -0.35 |
Net Income | 163.62 | 183.45 | -47.58 | -284.23 | -293.65 | -290.02 |
Earnings From Discontinued Operations | 220.19 | 241.66 | 105.52 | 38.74 | - | - |
Net Income to Common | 163.62 | 183.45 | -47.58 | -284.23 | -293.65 | -290.02 |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change (YoY) | 0.58% | 1.02% | 2.82% | 3.98% | 1.33% | 2.78% |
EPS (Basic) | 40.46 | 45.37 | -11.89 | -73.00 | -78.50 | -78.50 |
EPS (Diluted) | 40.46 | 45.37 | -11.89 | -73.00 | -78.50 | -78.50 |
Shares Outstanding | 4.05 | 4.05 | 4.04 | 3.95 | 3.77 | 3.72 |
Free Cash Flow | -21.4 | -4.81 | -138.27 | -317.54 | -149.67 | -87.42 |
Free Cash Flow Per Share | -5.29 | -1.19 | -34.55 | -81.59 | -39.98 | -23.67 |
Gross Margin | 40.70% | 91.37% | 47.47% | 91.53% | 85.59% | 94.53% |
Operating Margin | -602.14% | -712.65% | -507.80% | -689.53% | -213.90% | -122.62% |
Profit Margin | -760.47% | -903.79% | -516.86% | -690.06% | -209.27% | -123.38% |
FCF Margin | -287.70% | -74.72% | -466.78% | -678.46% | -106.35% | -37.15% |
EBITDA | -44.37 | -45.15 | -147.72 | -312.79 | -290.42 | -273.72 |
EBITDA Margin | -596.38% | -701.04% | -498.71% | -668.31% | -206.36% | -116.32% |
EBIT | -44.79 | -45.9 | -150.42 | -322.72 | -301.03 | -288.53 |
EBIT Margin | -602.14% | -712.65% | -507.80% | -689.53% | -213.90% | -122.62% |
Effective Tax Rate | -0.16% | -0.15% | -0.18% | -0.08% | 0.12% | 0.12% |